We support innovative, high-impact research focused on improving outcomes for children and young adults with sarcoma.
In 2026, Strides for Sarcoma awarded the inaugural $40,000 Maia James Sarcoma Innovation Grant to Dr. Pengda Liu at the University of North Carolina. His team is developing novel antibody-drug conjugates for relapsed Ewing sarcoma, with the goal of identifying more precise treatment strategies for children whose disease has returned.
In 2024, Strides for Sarcoma donated $7,500 to Dr. Karen Pollok’s laboratory at Indiana University School of Medicine to support pediatric sarcoma research. This early investment marked an important step in our commitment to funding scientists working to create better options for young patients.
Strides contributed $2,500 to Dr. Ed Greenfield’s laboratory at Indiana University School of Medicine for metastatic osteosarcoma research, supporting work focused on a cancer that primarily affects children, adolescents, and young adults.
Strides also provided $2,500 to Dr. Christopher Collier at Indiana University School of Medicine for sarcoma research, helping strengthen a growing portfolio of investments across pediatric bone and soft-tissue sarcomas.
Pediatric sarcomas are rare, biologically diverse, and often difficult to treat after relapse. Strategic research investments can help scientists validate new targets, test promising therapies, and generate the preliminary evidence needed to compete for larger grants.
Every research gift made through Strides is an investment in better treatment, less toxicity, and more birthdays.